Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIV.L Regulatory News (RIV)

  • There is currently no data for RIV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - River & Mercantile Group plc

6 Dec 2021 08:12

Form 8.5 (EPT/RI) - River & Mercantile Group plc

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the “Code”)

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree River & Mercantile Group plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Broker and Financial advisor to Premier Miton Group plc
(d) Date dealing undertaken: 3rd December 2021
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”Premier Miton Group plc AssetCo plc

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary SharesSale 5,000316.56316.56

 

(b) Cash-settled derivative transactions

 

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
        

 

(ii) Exercise

 

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
    

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
 

 

 

Date of disclosure:6th December 2021
Contact name:Jacqueline Lovis
Telephone number:+44 207 678 4815

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
5th Nov 20181:19 pmRNSAnnual Report and Annual General Meeting 2018
2nd Nov 20184:40 pmRNSSecond Price Monitoring Extn
2nd Nov 20184:35 pmRNSPrice Monitoring Extension
2nd Nov 201810:27 amRNSDirector/PDMR Shareholding
31st Oct 20187:00 amRNSTrading Statement
15th Oct 20181:32 pmRNSDirector/PDMR Shareholding
10th Oct 20182:20 pmRNSDirector/PDMR Shareholding
4th Oct 20185:26 pmRNSDirector/PDMR Shareholding
4th Oct 20185:23 pmRNSDirector/PDMR Shareholding
27th Sep 20184:40 pmRNSSecond Price Monitoring Extn
27th Sep 20184:35 pmRNSPrice Monitoring Extension
24th Sep 20187:00 amRNSFinal Results
6th Sep 201810:08 amRNSChanges of Executive Directors' responsibilities
3rd Sep 20184:35 pmRNSPrice Monitoring Extension
30th Aug 20184:35 pmRNSPrice Monitoring Extension
29th Aug 20184:40 pmRNSSecond Price Monitoring Extn
29th Aug 20184:35 pmRNSPrice Monitoring Extension
20th Aug 20183:06 pmRNSNotice of Results
14th Aug 201812:03 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSTrading Statement
19th Jul 201810:10 amRNSCMA Investment Consultants Investigation response
16th Jul 201812:48 pmRNSDirector/PDMR Shareholding
12th Jul 20187:00 amRNSRMMIC Update
10th Jul 20182:07 pmRNSDirector/PDMR Shareholding - Replacement
10th Jul 201811:29 amRNSHolding(s) in Company
10th Jul 201811:09 amRNSDirector/PDMR Shareholding
6th Jul 20185:44 pmRNSDirector/PDMR Shareholding
6th Jul 20187:00 amRNSTrading Statement
26th Jun 20185:19 pmRNSDirector/PDMR Shareholding
26th Jun 20181:57 pmRNSDirector/PDMR Shareholding
25th Jun 20185:56 pmRNSDirector/PDMR Shareholding
22nd Jun 20187:00 amRNSStaff appointment and office establishment
20th Jun 20184:25 pmRNSHolding(s) in Company
19th Jun 20183:31 pmRNSStaff appointment and office establishment
18th Jun 20187:00 amRNSDirector/PDMR Shareholding
1st Jun 201811:30 amRNSInclusion in the FTSE UK Index Series
21st May 20181:48 pmRNSHolding(s) in Company
11th May 20187:00 amRNSTotal Voting Rights
1st May 20184:06 pmRNSDirector/PDMR Shareholding
23rd Apr 20187:00 amRNSTrading Statement
9th Apr 20185:11 pmRNSDirector/PDMR Shareholding
5th Apr 201812:00 pmRNSCompany only interim results
29th Mar 20185:24 pmRNSChange of Registered Office
21st Mar 20182:30 pmRNSTotal Voting Rights
16th Mar 20184:30 pmRNSDirector/PDMR Shareholding
15th Mar 20184:35 pmRNSPrice Monitoring Extension
14th Mar 20183:50 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSHalf-year Report
19th Feb 201810:15 amRNSDirectorate Change
7th Feb 20189:32 amRNSNotification of Portfolio Manager Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.